New FDA COVID-19 vaccine guidance requires two months of follow-up data for approval

New guidelines issued by the Food and Drug Administration on Tuesday require manufacturers of potential new COVID-19 vaccines to provide two months' worth of " follow-up " data on their safety.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news